FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology, and concerns simulation in vivo of cortical cataract. That is ensured by a double-side surgical sympathectomy by excising a superior cervical sympathetic ganglion.
EFFECT: by simplicity and effectiveness of modulation, the method provides forming the cortical lens-form opacity, which is morphologically and immunohistochemically identical to lens cell changes in age-related lens opacity in a human.
6 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF CORTICAL TYPE OF AGE CATARACT | 2009 |
|
RU2418568C2 |
METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR TYPE OF AGE CATARACT | 2009 |
|
RU2411926C2 |
NEW EYE DROPLETS FOR CONSERVATIVE TREATMENT AND PREVENTION OF THE AGE-RELATED NUCLEAR CATARACT | 2015 |
|
RU2637875C2 |
METHOD FOR PREDICTION OF AGE-SPECIFIC CATARACT TYPE PRIOR TO CONTRACTION THEREOF | 2008 |
|
RU2371098C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING SECONDARY SPECIFIC CATARACT | 2012 |
|
RU2512744C1 |
EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
IMPROVED EYE DROPS FOR PREVENTION AND TREATMENT OF EARLY MANIFESTATIONS OF AGE-RELATED NUCLEAR CATARACT | 2020 |
|
RU2748598C1 |
METHOD FOR MODELING CATARACTS IN LABORATORY RATS | 2023 |
|
RU2809320C1 |
MODIFIED METHOD FOR DETECTING LENTICULAR CELLULAR STRUCTURES IN EXPERIMENTAL ANIMALS | 2005 |
|
RU2319132C2 |
THERAPY OF EARLY CATARACT | 2008 |
|
RU2367387C1 |
Authors
Dates
2015-06-20—Published
2011-01-18—Filed